167 related articles for article (PubMed ID: 22918509)
1. Cytoplasmic localization of PML particles in laminopathies.
Houben F; De Vos WH; Krapels IP; Coorens M; Kierkels GJ; Kamps MA; Verstraeten VL; Marcelis CL; van den Wijngaard A; Ramaekers FC; Broers JL
Histochem Cell Biol; 2013 Jan; 139(1):119-34. PubMed ID: 22918509
[TBL] [Abstract][Full Text] [Related]
2. Soft substrates normalize nuclear morphology and prevent nuclear rupture in fibroblasts from a laminopathy patient with compound heterozygous LMNA mutations.
Tamiello C; Kamps MA; van den Wijngaard A; Verstraeten VL; Baaijens FP; Broers JL; Bouten CC
Nucleus; 2013; 4(1):61-73. PubMed ID: 23324461
[TBL] [Abstract][Full Text] [Related]
3. The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling.
Lång E; Grudic A; Pankiv S; Bruserud O; Simonsen A; Bjerkvig R; Bjørås M; Bøe SO
Blood; 2012 Jul; 120(4):847-57. PubMed ID: 22692509
[TBL] [Abstract][Full Text] [Related]
4. A Novel Lamin A Mutant Responsible for Congenital Muscular Dystrophy Causes Distinct Abnormalities of the Cell Nucleus.
Barateau A; Vadrot N; Vicart P; Ferreiro A; Mayer M; Héron D; Vigouroux C; Buendia B
PLoS One; 2017; 12(1):e0169189. PubMed ID: 28125586
[TBL] [Abstract][Full Text] [Related]
5. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins.
Jul-Larsen A; Grudic A; Bjerkvig R; Bøe SO
J Cell Sci; 2009 Apr; 122(Pt 8):1201-10. PubMed ID: 19339552
[TBL] [Abstract][Full Text] [Related]
6. Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations.
Muchir A; Medioni J; Laluc M; Massart C; Arimura T; van der Kooi AJ; Desguerre I; Mayer M; Ferrer X; Briault S; Hirano M; Worman HJ; Mallet A; Wehnert M; Schwartz K; Bonne G
Muscle Nerve; 2004 Oct; 30(4):444-50. PubMed ID: 15372542
[TBL] [Abstract][Full Text] [Related]
7. PML regulates PER2 nuclear localization and circadian function.
Miki T; Xu Z; Chen-Goodspeed M; Liu M; Van Oort-Jansen A; Rea MA; Zhao Z; Lee CC; Chang KS
EMBO J; 2012 Mar; 31(6):1427-39. PubMed ID: 22274616
[TBL] [Abstract][Full Text] [Related]
8. Protein profiling reveals energy metabolism and cytoskeletal protein alterations in LMNA mutation carriers.
Magagnotti C; Bachi A; Zerbini G; Fattore E; Fermo I; Riba M; Previtali SC; Ferrari M; Andolfo A; Benedetti S
Biochim Biophys Acta; 2012 Jun; 1822(6):970-9. PubMed ID: 22326558
[TBL] [Abstract][Full Text] [Related]
9. Repetitive disruptions of the nuclear envelope invoke temporary loss of cellular compartmentalization in laminopathies.
De Vos WH; Houben F; Kamps M; Malhas A; Verheyen F; Cox J; Manders EM; Verstraeten VL; van Steensel MA; Marcelis CL; van den Wijngaard A; Vaux DJ; Ramaekers FC; Broers JL
Hum Mol Genet; 2011 Nov; 20(21):4175-86. PubMed ID: 21831885
[TBL] [Abstract][Full Text] [Related]
10. Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies.
Broers JL; Peeters EA; Kuijpers HJ; Endert J; Bouten CV; Oomens CW; Baaijens FP; Ramaekers FC
Hum Mol Genet; 2004 Nov; 13(21):2567-80. PubMed ID: 15367494
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel muscle A-type lamin-interacting protein (MLIP).
Ahmady E; Deeke SA; Rabaa S; Kouri L; Kenney L; Stewart AF; Burgon PG
J Biol Chem; 2011 Jun; 286(22):19702-13. PubMed ID: 21498514
[TBL] [Abstract][Full Text] [Related]
12. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
[TBL] [Abstract][Full Text] [Related]
13. Nuclear-cytoplasmic shuttling of a RING-IBR protein RBCK1 and its functional interaction with nuclear body proteins.
Tatematsu K; Yoshimoto N; Koyanagi T; Tokunaga C; Tachibana T; Yoneda Y; Yoshida M; Okajima T; Tanizawa K; Kuroda S
J Biol Chem; 2005 Jun; 280(24):22937-44. PubMed ID: 15833741
[TBL] [Abstract][Full Text] [Related]
14. Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells.
Sourvinos G; Tavalai N; Berndt A; Spandidos DA; Stamminger T
J Virol; 2007 Sep; 81(18):10123-36. PubMed ID: 17626080
[TBL] [Abstract][Full Text] [Related]
15. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated Lamin A/C in the Nuclear Interior Binds Active Enhancers Associated with Abnormal Transcription in Progeria.
Ikegami K; Secchia S; Almakki O; Lieb JD; Moskowitz IP
Dev Cell; 2020 Mar; 52(6):699-713.e11. PubMed ID: 32208162
[TBL] [Abstract][Full Text] [Related]
17. Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles.
Becker KA; Florin L; Sapp C; Maul GG; Sapp M
J Virol; 2004 Feb; 78(3):1121-8. PubMed ID: 14722267
[TBL] [Abstract][Full Text] [Related]
18. Regulation of apoptosis by PML and the PML-NBs.
Bernardi R; Papa A; Pandolfi PP
Oncogene; 2008 Oct; 27(48):6299-312. PubMed ID: 18931695
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic PML: from molecular regulation to biological functions.
Jin G; Gao Y; Lin HK
J Cell Biochem; 2014 May; 115(5):812-8. PubMed ID: 24288198
[TBL] [Abstract][Full Text] [Related]
20. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
